OVA (323-339)

OVA (323-339) is a synthetic peptide fragment derived from the ovalbumin protein, corresponding to amino acid residues 323 through 339. As a well-characterized epitope, this peptide is widely recognized for its immunological relevance, particularly in studies involving antigen processing and presentation. Its defined sequence and established role in T cell recognition have made it a benchmark tool for immunological research, especially within the context of major histocompatibility complex (MHC) class II pathways. The utility of OVA (323-339) extends across a range of experimental systems, providing a reliable model for dissecting cellular and molecular mechanisms underlying adaptive immune responses.

Epitope mapping: OVA (323-339) is extensively employed in epitope mapping studies to investigate the specificity of T cell receptors and the fine details of antigen recognition. By serving as a model peptide, it enables researchers to delineate the precise amino acid residues involved in T cell activation and to characterize the interaction dynamics between peptide-MHC complexes and T cell receptors. These insights are critical for understanding immune system function and for the rational design of peptide-based immunological assays.

Antigen presentation assays: The peptide is a gold standard substrate for evaluating antigen processing and presentation by antigen-presenting cells (APCs). Its defined sequence and immunodominant properties facilitate controlled studies on the efficiency and fidelity of peptide loading onto MHC class II molecules. Researchers utilize OVA (323-339) to probe the molecular mechanisms governing peptide binding, trafficking, and display on the cell surface, thereby advancing knowledge of immune surveillance and response modulation.

T cell activation studies: Due to its ability to specifically stimulate CD4+ T cells in various experimental models, OVA (323-339) is a preferred reagent for in vitro and ex vivo T cell activation assays. It allows for the quantitative and qualitative assessment of T cell proliferation, cytokine secretion, and differentiation in response to antigenic stimulation. These applications are foundational for immunological research, vaccine development, and the study of autoimmune processes.

Immunological assay calibration: The peptide is frequently used as a positive control in a range of immunological assay systems, including enzyme-linked immunospot (ELISpot), intracellular cytokine staining, and flow cytometry-based proliferation assays. Its reproducible activity and well-characterized immunogenicity make it an ideal standard for validating assay performance, optimizing experimental conditions, and benchmarking novel immunological reagents or protocols.

Peptide-MHC binding studies: OVA (323-339) serves as a reference ligand in biochemical and structural studies aimed at elucidating the principles of peptide binding to MHC class II molecules. By enabling detailed analysis of peptide-MHC interactions, it supports investigations into binding affinities, structural conformations, and the impact of sequence modifications on immunogenicity. Such studies inform the broader understanding of antigen presentation and guide the rational engineering of peptides for research and biotechnological applications.

1. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. Relatedness of antibodies to peptides containing homocitrulline or citrulline in patients with rheumatoid arthritis

4. The effect of sex on immune responses to a homocitrullinated peptide in the DR4-transgenic mouse model of Rheumatoid Arthritis

5. Myotropic activity of allatostatins in tenebrionid beetles